Portal:RenalGenomics/Other
From WikiPathways
(Difference between revisions)
Current revision (17:45, 4 December 2019) (view source) |
|||
(36 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | ==== | + | ==Renal Pathology== |
+ | * HIPK2 in kidney fibrosis [[Pathway:WP4751|(Homo sapiens)]] | ||
+ | * Nephrotic syndrome [[Pathway:WP4758|(Homo sapiens)]] | ||
+ | * Wnt Signaling in Kidney Disease [[Pathway:WP4150|(Homo sapiens)]] [[Pathway:WP3857|(Mus musculus)]] | ||
+ | * Polycystic Kidney Disease Pathway [[Pathway:WP2571|(Homo sapiens)]] | ||
+ | |||
+ | ===Glom and Podocyte=== | ||
+ | * Primary Focal Segmental Glomerulosclerosis FSGS [[Pathway:WP2572|(Homo sapiens)]] [[Pathway:WP2573|(Mus musculus)]] [[Pathway:WP3233|(Bos taurus)]] | ||
+ | * PodNet: protein-protein interactions in the podocyte [[Pathway:WP2310|(Mus musculus)]] | ||
+ | * XPodNet - protein-protein interactions in the podocyte expanded by STRING [[Pathway:WP2309|(Mus musculus)]] | ||
- | ==Proximal Nephron== | + | ===Proximal Nephron=== |
* Proximal Tubule Transporters [[Pathway:WP3881|(Rattus norvegicus)]] | * Proximal Tubule Transporters [[Pathway:WP3881|(Rattus norvegicus)]] | ||
- | * Hexoses | + | * Hexoses Metabolism in Proximal Tubules [[Pathway:WP3916|(Rattus norvegicus)]] |
- | * Fructose | + | * Fructose Metabolism in Proximal Tubules [[Pathway:WP3894|(Rattus norvegicus)]] |
- | * Polyol Pathway [[Pathway:WP690|(Homo sapiens)]] | + | * Polyol Pathway [[Pathway:WP690|(Homo sapiens)]] [[Pathway:WP1265|(Mus musculus)]] [[Pathway:WP1303|(Rattus norvegicus)]] [[Pathway:WP1054|(Bos taurus)]] |
* Lipid Droplet Metabolism [[Pathway:WP3901|(Rattus norvegicus)]] | * Lipid Droplet Metabolism [[Pathway:WP3901|(Rattus norvegicus)]] | ||
- | ==Distal Nephron== | + | ===Distal Nephron=== |
* Thick Ascending Limb Transport [[Pathway:WP3882|(Rattus norvegicus)]] | * Thick Ascending Limb Transport [[Pathway:WP3882|(Rattus norvegicus)]] | ||
* Angiotensin Signaling in Thick Ascending Limbs [[Pathway:WP3887|(Rattus norvegicus)]] | * Angiotensin Signaling in Thick Ascending Limbs [[Pathway:WP3887|(Rattus norvegicus)]] | ||
* Vasopressin Regulates Renal Water Homeostasis Via Aquaporins [[Pathway:WP2662|(Homo sapiens)]] | * Vasopressin Regulates Renal Water Homeostasis Via Aquaporins [[Pathway:WP2662|(Homo sapiens)]] | ||
+ | * Distal Convoluted Tubule 1 (DCT1) Cell [[Pathway:WP4183|(Mus musculus)]] | ||
- | ==Renal | + | ===Renal cell carcinoma=== |
- | * | + | * Pathways in clear cell renal cell carcinoma [[Pathway:WP4018|(Homo sapiens)]] |
- | * | + | * Type 2 papillary renal cell carcinoma [[Pathway:WP4241|(Homo sapiens)]] |
- | * | + | * MET in type 1 papillary renal cell carcinoma [[Pathway:WP4205|(Homo sapiens)]] |
+ | * Hereditary leiomyomatosis and renal cell carcinoma pathway [[Pathway:WP4206|(Homo sapiens)]] | ||
+ | * Tumor suppressor activity of SMARCB1[[Pathway:WP4204|(Homo sapiens)]] | ||
- | ==Other | + | ==Other pathways== |
* Renin-Angiotensin System [[Pathway:WP376|(Rattus norvegicus)]] | * Renin-Angiotensin System [[Pathway:WP376|(Rattus norvegicus)]] | ||
- | * Vitamin D Metabolism [[Pathway:WP1531|(Homo sapiens)]][[Pathway:WP3162|(Bos taurus)]] | + | * ACE Inhibitor Pathway [[Pathway:WP554|(Homo sapiens)]] [[Pathway:WP1033|(Bos taurus)]] |
+ | * Endothelin Pathways [[Pathway:WP2197|(Homo sapiens)]] [[Pathway:WP3246|(Bos taurus)]] | ||
+ | * Vitamin D Metabolism [[Pathway:WP1531|(Homo sapiens)]] [[Pathway:WP3162|(Bos taurus)]] | ||
+ | * Vitamin D Metabolism II [[Pathway:WP3685|(Homo sapiens)]] | ||
- | == | + | ==Pathways under construction== |
+ | * Tg26 glom [[Pathway:WP4749|(Mus musculus)]] | ||
- | * | + | == Suggested Contributions == |
- | * | + | * Membranoproliferative Glomerulonephritis type II |
+ | * Acute Kidney Injury | ||
+ | * Chronic Kidney Disease | ||
+ | * Diabetic Nephropathy | ||
+ | * Kidney Transplants and Rejection | ||
+ | * Mitochondria in Renal Disease | ||
+ | * Membranous Nephropathy | ||
+ | * Immune System and the Kidney | ||
+ | * Renovascular Hypertension | ||
+ | * Salt-Sensitive Hypertension |
Current revision
Contents |
Renal Pathology
- HIPK2 in kidney fibrosis (Homo sapiens)
- Nephrotic syndrome (Homo sapiens)
- Wnt Signaling in Kidney Disease (Homo sapiens) (Mus musculus)
- Polycystic Kidney Disease Pathway (Homo sapiens)
Glom and Podocyte
- Primary Focal Segmental Glomerulosclerosis FSGS (Homo sapiens) (Mus musculus) (Bos taurus)
- PodNet: protein-protein interactions in the podocyte (Mus musculus)
- XPodNet - protein-protein interactions in the podocyte expanded by STRING (Mus musculus)
Proximal Nephron
- Proximal Tubule Transporters (Rattus norvegicus)
- Hexoses Metabolism in Proximal Tubules (Rattus norvegicus)
- Fructose Metabolism in Proximal Tubules (Rattus norvegicus)
- Polyol Pathway (Homo sapiens) (Mus musculus) (Rattus norvegicus) (Bos taurus)
- Lipid Droplet Metabolism (Rattus norvegicus)
Distal Nephron
- Thick Ascending Limb Transport (Rattus norvegicus)
- Angiotensin Signaling in Thick Ascending Limbs (Rattus norvegicus)
- Vasopressin Regulates Renal Water Homeostasis Via Aquaporins (Homo sapiens)
- Distal Convoluted Tubule 1 (DCT1) Cell (Mus musculus)
Renal cell carcinoma
- Pathways in clear cell renal cell carcinoma (Homo sapiens)
- Type 2 papillary renal cell carcinoma (Homo sapiens)
- MET in type 1 papillary renal cell carcinoma (Homo sapiens)
- Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens)
- Tumor suppressor activity of SMARCB1(Homo sapiens)
Other pathways
- Renin-Angiotensin System (Rattus norvegicus)
- ACE Inhibitor Pathway (Homo sapiens) (Bos taurus)
- Endothelin Pathways (Homo sapiens) (Bos taurus)
- Vitamin D Metabolism (Homo sapiens) (Bos taurus)
- Vitamin D Metabolism II (Homo sapiens)
Pathways under construction
- Tg26 glom (Mus musculus)
Suggested Contributions
- Membranoproliferative Glomerulonephritis type II
- Acute Kidney Injury
- Chronic Kidney Disease
- Diabetic Nephropathy
- Kidney Transplants and Rejection
- Mitochondria in Renal Disease
- Membranous Nephropathy
- Immune System and the Kidney
- Renovascular Hypertension
- Salt-Sensitive Hypertension